Targeted mosquito control to stop malaria in African cities
Spatial Targeting and Adaptive Vector Control for Residual Transmission and Malaria Elimination in Urban African Settings
This project develops flexible, neighborhood-focused mosquito-control approaches to lower malaria risk for people living in Malabo and similar urban areas.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11116948 on NIH RePORTER |
What this research studies
This project works with the Bioko Island malaria program to target mosquito control where infections continue in Malabo, the island's capital, using an approach called adaptive vector control. Researchers will map where mosquitoes bite, track human travel that brings infections from the mainland, and identify neighborhoods with ongoing transmission. Teams will then direct tools like bed nets, indoor spraying, and other local measures to those hotspots and monitor the results. As a resident, you may be asked to share travel or household information, allow mosquito or blood sampling, or take part in community interventions.
Who could benefit from this research
Good fit: Adults (21+) who live in Malabo, Bioko Island, especially those in neighborhoods with ongoing malaria transmission or with frequent travel to mainland Equatorial Guinea.
Not a fit: People who live outside the targeted urban areas, children under 21, or those not exposed to local or imported malaria transmission may not directly benefit from this work.
Why it matters
Potential benefit: Could reduce malaria cases and outbreaks in city neighborhoods by directing control efforts to the places and people at highest risk.
How similar studies have performed: Bioko Island previously achieved large declines in malaria with intensive control, and this project builds on those successes by applying a newer, targeted strategy that has had limited prior testing in urban elimination settings.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Smith, David L. — University of Washington
- Study coordinator: Smith, David L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.